MTOR and familial hypercholesterolemia: Postoperative complication of biliary stricture after LDLT and the use of mTOR inhibitor were independently associated with development of significant hypercholesterolemia after LDLT (odds ratio [OR] 2.09, 95% CI 1.39–3.13; p < 0.0001 and OR 1.97, 95% CI 1.13–3.41; p = 0.02, respectively) (Table 4).